A cost benefit analysis of the Luminex xTAG Gastrointestinal Pathogen Panel for detection of infectious gastroenteritis in hospitalised patients

Journal of Infection

Volumn 70, Issue 5, 2015, Pages 504-511

  Goldenberg, Simon D ^a   Bacelar, Mariana ^b   Brazier, Peter ^b   Bisnauthsing, Karen ^a   Edgeworth, Jonathan D ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b Partner Optimity Matrix   (United Kingdom)

Author keywords

Acute diarrhoea illness; Cost effectiveness; Gastroenteritis; Gastrointestinal bacteria; Gastrointestinal viruses; Infection control; Isolation days; Molecular diagnostics; XTAG GPP

Indexed keywords

ADENOVIRIDAE; ARTICLE; CAMPYLOBACTER; COST BENEFIT ANALYSIS; CRYPTOSPORIDIUM; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DIARRHEA; DISEASE CONTROL; ENTAMOEBA HISTOLYTICA; ENZYME IMMUNOASSAY; ESCHERICHIA COLI; GASTROENTERITIS; GASTROINTESTINAL PATHOGEN PANEL; GIARDIA; HOSPITAL PATIENT; HUMAN; INTERMETHOD COMPARISON; LABORATORY DEVICE; MAJOR CLINICAL STUDY; MICROBIAL IDENTIFICATION; NONHUMAN; NOROVIRUS; PATIENT CARE; PEPTOCLOSTRIDIUM DIFFICILE; ROTAVIRUS; SALMONELLA; SENSITIVITY ANALYSIS; SHIGELLA; VOMITING; AGED; BACTERIAL INFECTIONS; DIAGNOSTIC PROCEDURE; ECONOMICS; FEMALE; HOSPITALIZATION; INTESTINAL DISEASES, PARASITIC; MALE; MICROBIOLOGY; MOLECULAR DIAGNOSIS; PARASITOLOGY; VIROLOGY; VIRUS DISEASES;

AGED; BACTERIAL INFECTIONS; CLINICAL LABORATORY TECHNIQUES; COST-BENEFIT ANALYSIS; FEMALE; GASTROENTERITIS; HOSPITALIZATION; HUMANS; INTESTINAL DISEASES, PARASITIC; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES; VIRUS DISEASES;

EID: 84927022623     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.11.009     Document Type: Article

References (21)

1. Carmeli Y., Samore M., Shoshany O., Rajs A., Stalnikowitz R. Utility of clinical symptoms versus laboratory tests for evaluation of acute gastroenteritis. Dig Dis Sci 1996, 41:1749-1753.
2. Jansen A., Stark K., Kunkel J., et al. Aetiology of community-acquired, acute gastroenteritis in hospitalised adults: a prospective cohort study. BMC Infect Dis 2008, 8:143.
3. van den Brandhof W.E., De Wit G.A., de Wit M.A., van Duynhoven Y.T. Costs of gastroenteritis in the Netherlands. Epidemiol Infect 2004, 132:211-221.
4. Hellard M.E., Sinclair M.I., Harris A.H., Kirk M., Fairly C.K. Cost of community associated gastroenteritis. J Gastroenterol Hepatol 2003, 18:322-328.
5. Thomas M.K., Majowicz S.E., Pollari F., Sockett P.N. Burden of acute gastrointestinal illness in Canada, 1999-2007: interim summary of NSAGI activities. Can Commun Dis Rep 2008, 34:8-15.
6. Tam C.C., Rodrigues L.C., Viviani L., et al. Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut 2012, 61:69-77.
7. Food Standards Agency. Annual report of the chief scientist 2012/13. Available at: [accessed 10.10.14]. http://www.food.gov.uk/sites/default/files/multimedia/pdfs/publication/cstar_2013.pdf.
8. Guarino A., Giannattasio A. New molecular approaches in the diagnosis of acute diarrhea: advantages for clinicians and researchers. Curr Opin Gastroenterol 2011, 27:24.
9. Amar C.F., East C.L., Gray J., Iturriza-Gomara M., Maclure E.A., McLauchlin J. Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: re-examination of the english case-control infectious intestinal disease study. Eur J Clin Microbiol Infect Dis 1993-1996, 2007(26):311-323.
10. de Boer R.F., Ott A., Kesztyüs B., Kooistra-Smid A.M. Improved detection of five major gastrointestinal pathogens by use of a molecular screening approach. J Clin Microbiol 2010, 48:4140-4146.
11. Halligan E., Edgeworth J., Bisnauthsing K., et al. Multiplex molecular testing for management of infectious gastroenteritis in a hospital setting: a comparative diagnostic and clinical utility study. Clin Microbiol Infect 2014, 20:O460-O467.
12. Siegel JD. 2007 guideline for isolation precautions: Preventing transmission of infectious agents in healthcare settings. published 2007. [accessed 20.02.14]. http://www.cdc.gov/hicpac/2007IP/2007isolationPrecautions.html.
13. ®) GPP) testing in the diagnosis of infectious gastroenteritis. Clin Microbiol Infect 2014, 20:O182-O187.
14. Mengelle C., Mansuy J.M., Prere M.F., et al. Simultaneous detection of gastrointestinal pathogens with a multiplex luminex-based molecular assay in stool samples from diarrhoeic patients. Clin Microbiol Infect 2013, 19:E458-E465.
15. Siah S.P., Merif J., Kaur K., et al. Improved detection of gastrointestinal pathogens using generalised sample processing and amplification panels. Pathology 2014, 46:53-59.
16. ® diarrhea ACE detection system. Epidemiol Infect 2013, 141:2111-2121.
17. McAuliffe G.N., Anderson T.P., Stevens M., et al. Systematic application of multiplex PCR enhances the detection of bacteria, parasites, and viruses in stool samples. J Infect 2013, 67:122-129.
18. Scottish Government HAI Task Force/Health Protection Scotland NHS Scotland MRSA screening pathfind programme. Final report volume 2: an assessment of the economics, implementation and modelling of universal MRSA screening 2011.
19. Medici M.C., Tummolo F., Calderaro A., et al. MLB1 astrovirus in children with gastroenteritis, Italy. Emerg Infect Dis 2014, 1:169-170.
20. Rovida F., Campanini G., Piralla A., Adzasehoun K.M., Sarasini A., Baldanti F. Molecular detection of gastrointestinal viral infections in hospitalized patients. Diagn Microbiol Infect Dis 2013, 77:231-235.
21. Sala-Farré M.R., Broner S., Moreno A., et al. Cases of acute gastroenteritis due to calicivirus in outbreaks: clinical differences by age and etiologic agent. Clin Microbiol Infect 2014, 20:793-798.